Inventor · disambiguated record
Bernd Jandeleit
Also filed as: JANDELEIT BERND
27 granted patents·12 pending applications·554 citations·filing 1999–2025
96Inventor score
Files withQUADRIGA BIOSCIENCES INC15SYMYX TECHNOLOGIES INC8XENOPORT INC8JANDELEIT BERND3MAXYMUNE THERAPEUTICS INC2
Top patents by PatentIndex Score
39 records- 0196US7351740B2Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and useXENOPORT INC·Filed 2006·Granted Apr 1, 2008·43 cites·48 claims
- 0296US6692914B1Polymer brushes for immobilizing molecules to a surface or substrate, where the polymers have water-soluble or water-dispersible segments and probes bonded theretoSYMYX TECHNOLOGIES INC·Filed 2000·Granted Feb 17, 2004·90 cites·81 claims
- 0395US9394237B2β-substituted β-amino acids and analogs as chemotherapeutic agentsQUADRIGA BIOSCIENCES INC·Filed 2015·Granted Jul 19, 2016·13 cites·24 claims
- 0495US6043363ASubstituted aminomethylphosphines, compositions and coordination complexes of same, their synthesis and processes using sameSYMYX TECHNOLOGIES INC·Filed 1999·Granted Mar 28, 2000·144 cites·10 claims
- 0593US7994218B2Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of useXENOPORT INC·Filed 2008·Granted Aug 9, 2011·14 cites·21 claims
- 0693US6177528B1Substituted aminomethylphosphines, compositions and coordination complexes of same, their synthesis and processes using sameSYMYX TECHNOLOGIES INC·Filed 1999·Granted Jan 23, 2001·58 cites·14 claims
- 0792US9861599B2Beta-substituted beta-amino acids and analogs as chemotherapeutic agentsQUADRIGA BIOSCIENCES INC·Filed 2016·Granted Jan 9, 2018·4 cites·21 claims
- 0891US6833276B2Polymer brushes for immobilizing molecules to a surface and having water-soluble or water-dispersible segments therein and probes bonded theretoSYMYX TECHNOLOGIES INC·Filed 2001·Granted Dec 21, 2004·30 cites·14 claims
- 0990US8168617B2Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of useJANDELEIT BERND·Filed 2008·Granted May 1, 2012·24 cites·25 claims
- 1089US9783487B2Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereofQUADRIGA BIOSCIENCES INC·Filed 2016·Granted Oct 10, 2017·8 cites·25 claims
- 1189US7592369B2Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and useXENOPORT INC·Filed 2007·Granted Sep 22, 2009·10 cites·44 claims
- 1282US9024055B2Acetaminophen conjugates, compositions and methods of use thereofACORDA THERAPEUTICS INC·Filed 2012·Granted May 5, 2015·5 cites·9 claims
- 1381US6124476ACatalyst ligands, catalyst compositions, catalyst metal complexes and processes for cross-coupling aromatic boron compounds with aromatic halogens or perfluoroalkylsulfonatesSYMYX TECHNOLOGIES INC·Filed 1999·Granted Sep 26, 2000·56 cites·30 claims
- 1480US7053076B2Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugsXENOPORT INC·Filed 2002·Granted May 30, 2006·12 cites·21 claims
- 1578US6559255B2Controlled free radical emulsion and water-based polymerizations and seeded methodologiesSYMYX TECHNOLOGIES INC·Filed 2000·Granted May 6, 2003·15 cites·4 claims
- 1675US7777070B2Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and useXENOPORT INC·Filed 2009·Granted Aug 17, 2010·1 cites·34 claims
- 1775US7727976B2Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugsXENOPORT INC·Filed 2005·Granted Jun 1, 2010·2 cites·30 claims
- 1873US2023348631A1Pharmaceutical compositions of chemotherapeutic agents based on beta-substituted beta-amino acid derivativesQUADRIGA BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1973US2025282895A1Pharmaceutical compositions of chemotherapeutic agents based on beta-substituted beta-amino acid derivativesQUADRIGA BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2073US2025339388A1Phenylalanine-based lat1 inhibitors and uses thereofMAXYMUNE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2165US10245246B2β-substituted β-amino acids and analogs as chemotherapeutic agentsQUADRIGA BIOSCIENCES INC·Filed 2017·Granted Apr 2, 2019·0 cites·11 claims
- 2265US2016296484A1Beta-substituted beta-amino acids and analogs as chemotherapeutic agentsQUADRIGA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 2362US12427124B1Phenylalanine-based LAT1 inhibitors and uses thereofMAXYMUNE THERAPEUTICS INC·Filed 2025·Granted Sep 30, 2025·0 cites·28 claims
- 2462US10246406B2Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereofQUADRIGA BIOSCIENCES INC·Filed 2018·Granted Apr 2, 2019·0 cites·24 claims
- 2561US2019185413A1Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereofQUADRIGA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 2660US10017459B2β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereofQUADRIGA BIOSCIENCES INC·Filed 2017·Granted Jul 10, 2018·0 cites·21 claims
- 2760US6472486B2Controlled stable free radical emulsion polymerization processesSYMYX TECHNOLOGIES INC·Filed 1999·Granted Oct 29, 2002·25 cites·60 claims
- 2859US10034847B2Beta-substituted beta-amino acids and analogs as chemotherapeutic agentsQUADRIGA BIOSCIENCES INC·Filed 2016·Granted Jul 31, 2018·0 cites·15 claims
- 2957US9937139B2β-substituted γ-amino acids and analogs as chemotherapeutic agentsQUADRIGA BIOSCIENCES INC·Filed 2017·Granted Apr 10, 2018·0 cites·9 claims
- 3056US8372881B2Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and useXENOPORT INC·Filed 2010·Granted Feb 12, 2013·0 cites·23 claims
- 3154US9682921B2β-substituted γ-amino acids and analogs as chemotherapeutic agentsQUADRIGA BIOSCIENCES INC·Filed 2016·Granted Jun 20, 2017·0 cites·10 claims
- 3254US2009099253A1Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of UseXENOPORT INC·Filed 2008·Application pending·0 cites
- 3354US2023285572A1Targeted delivery of therapeutic agentsSEPELO THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 3447US2009082464A1Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of useJANDELEIT BERND·Filed 2008·Application pending·0 cites
- 3547US2005158879A1Polymer brushes for immobilizing molecules to a surface and having water-soluble or water-dispersible segments therein and probes bonded theretoSYMYX TECHNOLOGIES INC·Filed 2004·Application pending·0 cites
- 3646US9394236B2β-substituted γ-amino acids and analogs as chemotherapeutic agentsQUADRIGA BIOSCIENCES INC·Filed 2015·Granted Jul 19, 2016·0 cites·55 claims
- 3743US2016346240A1Methods of chemotherapy using chemotherapeutic agents based on beta-substituted beta-amino acids and analogsQUADRIGA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 3836US2011294879A1Method of treatment of fragile x syndrome, down's syndrome, autism and related disordersJANDELEIT BERND·Filed 2011·Application pending·0 cites
- 3929US2002010267A1Block copolymersSYMYX TECHNOLOGIES INC A DELAW·Filed 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bernd Jandeleit files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →